1 Department of Anatomy and Cell Biology and 2 Department of Environmental and Occupational Health, Kochi Medical School, Nankoku, Kochi 783-8505, Japan
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the liver, function of the bile salt export pump (Bsep), a major canalicular exporter of bile salts, is complemented by activity of the multidrug resistance protein 2 (Mrp2), a canalicular organic anions transporter. Mrp2 was found capable of transporting various anticancer drugs out of cells, eventually undermining their therapeutic potential and contributing to multidrug resistance. We employed a RT-PCR, immunoblotting, and immunofluorescence to examine their gene, protein expression, and distribution of antigenic sites in the rat liver during development from 16-day-old fetus to adult animal. Bsep mRNA was almost undetectable before birth. It was first clearly expressed in the liver of newborn rats. On the contrary, Mrp2 mRNA was seen before birth, although at low levels. In concert with mRNA expression, Bsep protein was undetectable before birth, while Mrp2 protein was already expressed. Both proteins were clearly detectable in the postnatal period. Confocal immunofluorescent microscopy showed asynchronous appearance of Bsep and Mrp2 proteins during development but their colocalization in the bile canaliculi once each one is expressed. During the gestational period, a weak immunofluorescence for Mrp2 was observed only in livers of 16-day-old embryos. No fluorescence for Bsep was seen. Both proteins were clearly visualizable after birth, although the pattern of immunostaining varied. These findings provide molecular evidence that expression of both Bsep and Mrp2 during development is transcriptionally regulated. They also point out the differences in relevance to the liver function of the systems responsible for canalicular transport of bile salts versus organic anions.
canalicular transporters; rat; ATP-binding cassette proteins; ontogenesis
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
FORMATION OF BILE is a unique function of the liver. Secretion of bile is an ATP-dependent process maintained by the function of specific transport ATPases (1, 12, 31, 39, 50). These independent canalicular transport systems belong to the superfamily of ATP-binding cassette (ABC) transporters and share common structural and functional characteristics (15, 29, 32, 48). ABC proteins are identified in various tissues and some of them were shown to be involved in multidrug resistance. They are also responsible for more restricted organ-specific functions depending on where they are expressed. In the liver, canalicular bile export pump (Bsep), also known as the sister of P-glycoprotein, is the major canalicular bile salt export pump of mammalian liver (7, 13). It was found that mutation of the gene encoding for a liver-specific ABC transporter leads to a progressive familial cholestasis type 2 (19, 42). Results were obtained demonstrating that Bsep plays an important role in the induction of intrahepatic cholestasis in mammalian liver (41). In addition, the canalicular isoform of the multidrug resistance-associated protein 2 (Mrp2), synonym to the canalicular multispecific organic anion transporter (cMOAT), is also confined to the canalicular domain and complements the function of Bsep by mediating export of amphipathic anionic substrates (22, 28, 40, 46). In cultured cells, MRP2, a member of the MRP gene family, confers drug resistance by exporting cytotoxic drugs out of cells and therefore represents an important therapeutical target for development of inhibitors that can potentially interfere with this transport (4, 9). Both Bsep and Mrp2 have been recently cloned and sequenced (5, 13, 34).
Earlier studies established that specific hepatic functions are acquired at different stages of liver development. This process has been described as a precisely orchestrated series of molecular and morphogenetic events (11, 14, 16, 30). Mechanisms that govern Bsep and Mrp2 expression during development are of practical significance, because it was demonstrated that incomplete development of the bile salt transporting system by the end of the gestation period results in numerous pathological alterations (43). Immature function of hepatic excretion may cause a harmful accumulation of drugs in the plasma and increase susceptibility of the liver to cholestasis (21, 38). Recent investigations documented that cholestasis, either extra- or intrahepatic, reduces expression of Bsep and Mrp2 at the mRNA and protein levels (36, 45, 49). It is noteworthy that Mrp2 is affected by extrahepatic cholestasis significantly stronger than Bsep, attempting to suggest that stability of the expression of these canalicular transporters is different, and therefore mechanisms of regulation and physiological relevance to liver functions vary (26). A recent study examined hepatic bile salt and organic anion transporters in pregnant and postpartum rats and found their differential regulation (6). However, Bsep and Mrp2 were not characterized in the developing liver. Therefore, in the present study, we evaluated the gene and protein expression as well as in situ localization of Bsep and Mrp2 during development of rat liver from 16-day-old fetus to adult animal.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animals. Pregnant Sprague-Dawley rats with known mating dates were laparotomized at 16 and 20 days of gestation. Other experimental animals included newborn (23 days in utero), 1-wk-old, and adult rats. Newborn rats were killed after suckling. All procedures were approved by the Institutional Research Animal Care Committee.
Total RNA isolation. Total RNA was extracted using a Teflon homogenizer with the Isogen reagent (Nippon Gene, Tokyo, Japan) and quantified using ultraviolet absorbance at 260 nm. Integrity of samples was confirmed by gel electrophoresis.
Semiquantitative RT-PCR. Random primed synthesis of the first-strand cDNA from total RNA and PCR with specific primers was performed using a BcaBEST RNA PCR kit (Takara, Osaka, Japan). One milligram of total RNA used for RT reaction was then divided into five aliquots for PCR. For the purpose of quantitation, GAPDH was used as internal control to normalize differences in cDNA loading. Specific primers were designed by analyzing the corresponding cDNA sequences (GenBank accession nos. U69487, L49379, and AF106860 for Bsep, Mrp2, and GAPDH, respectively) using the OLIGO primer analysis software. The primer sequences were as follows: 1) for Bsep (447-994): 5' TGC TTA TGG GAG GCG TAT 3' (upper primer), 5' GGG CTG ACA GCA AGA ATC 3' (lower primer); 2) for Mrp2 (677-1472): 5' GTC ACG GCT TCC TTT CTG 3' (upper primer), 5' AAC CCC AAC ACC TGC TAA 3' (lower primer); 3) for GAPDH (942-1373): 5' CAA CGA CCC CTT CAT TGA 3' (upper primer), 5' CAG TGA TGC CAT GCA CTG 3' (lower primer). The amplified products for Bsep, Mrp2, and GAPDH were predicted to be 565, 813, and 449 bp in length, respectively. Preliminary experiments showed linear increase of the accumulation of PCR products at different amplification cycles (26 for Bsep and Mrp2 and 24 for GAPDH), and therefore, PCR amplification was performed accordingly. It was carried out as follows: denaturation at 94°C for 30 s, annealing at 56°C for 30 s, extension at 72°C for 1 min. Sequences of PCR products were confirmed in a separate experiment using the direct sequencing method (data not shown).
RT-PCR products were electrophoresed on 1.8% agarose gel and stained with ethidium bromide. DNA bands were visualized under ultraviolet light, and photoimage was recorded using an epifluorescence detector Epi-Light ultraviolet FA 1100 (Aisin Cosmos R&D, Nagoya, Japan). Photoimages were scanned at 300 dpi and quantified using the NIH Image 1.6 software.Western blotting.
Approximately 50 mg of liver tissue was obtained from fetuses and rats
of different age as described (13) with some modifications and proceeded similarly in all groups examined. The tissue was briefly
washed free of blood and cut into small pieces in an ice-cold extraction buffer (250 mM/l sucrose, 95 mM/l NaCl, 45 mM/l Tris-HCl, pH
7.6), containing 0.025 trypsin inhibitor unit/ml of aprotinin and 0.1 mM/l phenylmethysulfonyl fluoride to eliminate the possible contribution of proteases (44). Samples were then
homogenized in 10 vol of the buffer with a Polytron homogenizer
(Kinematica, Lucerne, Switzerland) for 5 min. After filtration through
the cheesecloth, the homogenate was centrifuged at 3,000 rpm for 30 min
to remove cell debris. The pellet was discarded, and the collected supernatant was ultracentrifuged (model TL-100; Beckman Instruments, Palo Alto, CA) at 100,000 g for 1 h. The resulting
pellet containing fractions of membrane proteins was recovered and
suspended in a membrane suspension buffer (50 mM/l Tris · HCl
buffer, pH 7.6, containing 50 mM/l HEPES, 0.2 mM/l
D-gluconic acid, and 250 mM/l sucrose). Concentration of
proteins was measured with the DC protein assay method (Bio-Rad,
Hercules, CA) using BSA as a standard. Proteins were aliquoted and
stored at 70°C until further use. Equal amounts (~25 µg) of
proteins were then boiled for 3 min in a sample buffer and separated
through 10% SDS-PAGE (Bio-Rad) according to Laemmli (25)
using a Mini-Protean II electrophoretic apparatus (Bio-Rad). Prestained
protein molecular weight markers (Vector Laboratories, Burlingame, CA)
were run in the same gels. Proteins were then transferred onto
polyvinylidene difluoride (PVDF) membranes by electroblotting. Ponceau
S staining was performed to check for the equal protein transfer.
Nonspecific binding was blocked by incubation in 5% skim milk in
Tris-buffered saline (TBS) containing 0.1% Tween 20 Tris-base sodium
(TTBS), pH 7.6, overnight at 0-4°C. Membranes were then probed
with the primary polyclonal anti-Bsep and monoclonal anti-Mrp2
antibodies, diluted 1:2,000 and 1:5,000, respectively, for 1 h at
room temperature. The antibody was raised against the COOH terminus of
Bsep, an ~160-kDa protein (13). Anti-Mrp2 antibody
(M-2III6) was obtained commercially (Alexis Biochemicals, San Diego,
CA). The antibody reacts with the internal epitope of cMOAT/Mrp2, a
190- to 200-kDa transmembrane protein (34). It does not
cross-react with the Mdr1, Mrp1, Mrp3,
and Mrp5 gene products (23). After membranes were washed in TTBS, they were incubated with the corresponding biotinylated secondary antibodies (Vector Laboratories), diluted 1:2,000, for another 1 h. Finally, the membranes were incubated with the biotin-horseradish peroxidase-streptavidin complex (Vector Laboratories), diluted 1:10,000, for 30-45 min at room
temperature. After extensive washing with TTBS, membranes were exposed
to the enhanced chemiluminescence-plus reagents (Amersham) according to
the manufacturer's protocol. Emitted light was documented on a Fuji
RX-U X-ray film.
Immunofluorescent microscopy.
Livers were excised, cut on small pieces, embedded in optimum cutting
temperature compound (Miles, Elkhart, IN), and frozen in liquid
nitrogen. After cutting with a cryostat, sections (6-8 µm thick)
were picked up on poly-L-lysine-coated glass slides, air-dried, and exposed to acetone for 30 min at 20°C. Nonspecific binding was blocked with 10% goat serum in TBS for 30 min. The sections were then incubated with the mixture of rabbit anti-Bsep antibody (final dilution 1:100) and mouse anti-Mrp2 antibody (final dilution 1:50) for 1 h at room temperature. After rinsing with TBS, the sections were incubated with the mixture of corresponding secondary antibodies (conjugated with Alexa 488 and Alexa 594, respectively; Molecular Probes, Eugene, OR), diluted 1:400, for another
1 h at RT. After a final washing procedure, the sections were
mounted with a ProLong antifade reagent (Molecular Probes, Leiden, The
Netherlands), coverglassed and examined using confocal optics. In
controls, specimens were either incubated with nonimmune IgG or the
primary antibody was omitted from the labeling process.
Confocal laser scanning microscopy and imaging. Immunocytochemical staining was examined using a confocal laser scanning microscope LSM 410 (Carl Zeiss, Jena, Germany), which is capable for accurate visualization of fluorescent markers, because the thin optical section generated by the instrument eliminates the confounding effects of out-of-focus fluorescence (51). Images were captured on MO disk and stored for further editing and enhancement. Digital images were processed on a Macintosh Dual G4 Power PC (Apple Computer, Cupertino, CA) and composed with Adobe Photoshop 6.0.1 software (Adobe Systems, San Jose, CA). Images, with contrast and brightness adjusted to optimally represent the original pattern of immunocytochemical staining, were printed out directly using a Fuji Pictrography 3000 printer (Fuji Photo Film, Tokyo, Japan).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
During pre- and postnatal development, liver acquires its functions via a precisely regulated chain of morphogenetic events. To find out when, how, and where Bsep and Mrp2 genes and proteins are expressed in the developing rat liver, we employed semiquantitative RT-PCR, immunoblotting, and confocal immunofluorescent microscopy.
Detection of Bsep and Mrp2 mRNA.
Bsep mRNA was practically undetectable in the liver of 16-day-old
fetuses. It was first clearly detected in the liver of newborn rats
(Fig. 1A). Thereafter, mRNA
expression levels underwent a steady and gradual increase. In adult
animals, its levels increased approximately three times compared with
the expression seen in newborn rats. Expression of Mrp2 mRNA showed a
different profile of the developmental increase (Fig.
2A). The first signs of Mrp2 mRNA were detected in the liver of 16-day-old fetuses, although level
of expression was very low. The level of expression almost doubled in
the liver of 20-day-old fetuses, but still accounted only for ~10%
of the level in adults (Fig. 2B). Liver of newborn rats
revealed more than triple increase of the level of Bsep mRNA expression
compared with 20-day-old fetuses (Fig. 1B). At birth, levels
of expression of both Bsep and Mrp2 constituted approximately one-third
of levels detected in adult animals. One-week-old pups showed further
increase of the expression. In the liver of adult rats, levels of Mrp2
mRNA expression were considerably higher.
|
|
Immunoblot detection of Bsep and Mrp2 protein.
Bsep protein was not expressed in fetal livers. With the birth of
animals, a band of the weight of ~160 kDa has become detectable (Fig.
3A). In postnatal period,
expression of Bsep protein underwent a very significant increase. On
the contrary, expression of Mrp2 protein (band of the weight of ~190
kDa) was detected in livers of 16- and 20-day-old fetuses and tended to
increase gradually after birth (Fig. 3B).
|
Immunofluorescent microscopy of Bsep and Mrp2.
Liver of 16-day-old fetuses consisted mainly of hematopoietic
stem cells and mitotically active hepatocytes. Hepatic cell cords were
seldom seen. No fluorescence for Bsep was detected (Fig.
4A), whereas weak staining for
Mrp2 was already noticed (Fig. 4, B and C). On
day 20 of gestation, the number of hematopoietic cells
decreased and embryonic liver revealed hepatic cell cords and
better-defined canalicular spaces. In more than one-half of preparations, antibodies for Bsep and Mrp2 stained what appeared to be
dilated bile canaliculi (Fig. 4, D and F). The
staining was coarse and extended to subapical portions of hepatocytes. Fluorescence for Mrp2 was more pronounced (Fig. 4E). At
birth, well-formed bile canaliculi displayed staining for both Bsep and Mrp2 (Fig. 5,
A-C). Anti-Bsep and anti-Mrp2 antibody
revealed the classic branching pattern of canaliculi. The antigens
appeared colocalized, however, intensity of fluorescence was stronger
for Bsep than for Mrp2. Although Bsep and Mrp2 remained confined to the
bile canalicular system, the staining pattern of canaliculi in the
newborn and adult rats was noticeably different. In the newborn
animals, the staining was seen as rather fuzzy (Fig. 5, A-C), whereas in adults it was very compact
and sharply defined the canaliculi (Fig. 5,
G-I). In livers of 1-wk-old rats,
fluorescence was frequently seen in subapical areas of hepatocytes
likely belonging to the so-called subapical compartment (Fig. 5,
D-F). Only occasionally similar areas showed
fluorescence in adult animals. Sinusoidal and basolateral domains of
the plasma membrane of hepatocytes as well as their cytoplasm were left
unstained in all preparations. Lobular gradients of staining for either
Bsep or Mrp2 were not noticed.
|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The goal of the present study was to obtain new information regarding the expression of Bsep and Mrp2, two independent canalicular transporters of mammalian liver, by following them during pre- and postnatal liver development. We examined gene expression of them to find that Mrp2 gene is expressed in the liver development earlier than Bsep. We detected that Mrp2 protein is expressed earlier as well. We also observed that, once expressed, Bsep and Mrp2 proteins share apical domain of the hepatocyte plasma membrane as their only in situ location in the liver, either in the pre- or postnatal period. What is of significance in these findings that can provide clues for better understanding of the function of these canalicular transporters?
Gene expression of Bsep, an ATP-dependent canalicular transporter of bile salt into bile, was first clearly detected in the liver of newborn rats, although a weak expression was seen in the liver of 20-day-old fetuses. After birth, levels of expression of mRNA showed gradual increase with its maximum detected in livers of adult animals. It should be mentioned that earlier studies reported that taurocholate, the predominant bile salt in the bile of adult rats, becomes detectable on day 10 of gestation. However, this is likely due to the occurrence of a mother-fetus transfer, because at this time the liver of the fetus is still in primordial state. Then, the size of the pool of bile salts continues to increase, although the rate of increase slows and concentration of bile salts at birth is yet to reach the levels of adulthood (27). After birth, secretion and reabsorption of bile salts in suckling rats continue to be reduced compared with adult animals (43, 52). The clear correlation between the Bsep gene expression and the time of birth when hepatocytes reveal all structural features of fully differentiated cells suggests that the molecular basis for Bsep function is already formed by this time. These results are in agreement with the report showing that expression of Bsep depends on cell differentiation (33) and supported by the current view that Bsep is a dominant ATP-dependent bile salt export pump of mammalian liver (13, 41).
Gene expression of Mrp2, another canalicular transporter that mediates
ATP-dependent transport of organic anions (e.g., bilirubin diglucuronide) into bile and contributes to the bile salt-independent bile flow, was different from that of Bsep. Mrp2 mRNA was first detected in the liver of 16-day-old fetuses, although the expression level was low. The level of expression doubled in livers of 20-day-old fetuses and then tripled in livers of newborn rats. Mrp2 mRNA expression did not appear to be stimulated by suckling as profoundly as
Bsep. It is known that Mrp2 is defective in Eisai hyperbilirubinemic and TR mutant rats (18, 34). In humans,
patients with mutations of the MRP2 gene develop the
Dubin-Johnson syndrome, an autosomal recessive liver disorder
characterized by chronic hyperbilirubinemia (34, 47).
Using cell culture, it was demonstrated that MRP2 is related to drug
resistance, because overexpression of MRP2 results in resistance to
carcinostatics (9, 17, 20, 23). MRP2 was also detected in
various carcinomas (22). Detectability of Mrp2 mRNA
earlier in the liver development, taken together with the observation
that suckling does not stimulate its expression as much as it
stimulates the expression of Bsep mRNA, may indicate that suckling
exerts different effects toward ATP-dependent canalicular transport of
organic anions versus bile salts.
Expression of Bsep and Mrp2 proteins during development was in general agreement with the expression of their mRNA. Bsep protein was clearly expressed only at the time of birth, whereas Mrp2 protein was identifiable before and after birth, thus indicating transcriptional regulation of both transporters during liver development. Considerable increase of the expression of Bsep mRNA and protein and Mrp2 mRNA between the 20-day-old fetus and a newborn demonstrates that the presence of these canalicular transporters rapidly increases during this period of time as the organ readies for its function after birth. It is worth mentioning that expression of Bsep mRNA and protein showed dissociation between the groups of newborn rats and 1-wk-old pups, tempting to assume that there might also be an involvement of additional mechanisms of posttranscriptional regulation. Further studies are required to clarify this issue.
Immunostaining for Bsep and Mrp2 proteins showed both antigens confined to the canalicular domain of the hepatocyte plasma membrane. It was noticed that intensity of Mrp2 immunofluorescence during development increased greater than its protein expression on Western blots. This may be due to the different sensitivity of these techniques. Both proteins were colocalized throughout all period of development, suggesting their affinity. This observation is in concert with the results of other investigators on the in situ localization of Bsep and Mrp2 and agrees with the study on polarization of the hepatocyte cell surface from the earliest time at which the liver is identifiable in the fetus (11, 13, 20). A very recent report of Akita et al. (2) gave further support to these findings by demonstrating coexpression of Bsep and Mrp2 in canalicular membrane vesicles. Importantly, immuocytochemical data showed that Bsep protein is not expressed in the liver of 16-day-old fetuses. Although weakly, both Bsep and Mrp2 are detectable in the liver on day 20 of embryonic development. At this time, Mrp2 protein is seen expressed stronger than Bsep. On the contrary, expression of Bsep is stronger than Mrp2 in the postnatal period. These observations may be explained by the fact that molecular composition of the plasma membrane domains in the fetal hepatocyte differs from that in the adult (11). It is also known that even in a late stage of fetal development, rat liver is yet to reach its fully differentiated state (16). Remarkably, changes of the developmental expression of Bsep and Mrp2 proteins observed here were consistent with the timing of structural maturation of the bile canaliculi and their secretory system (8). Changing patterns of immunocytochemical localization of Bsep and Mrp2 proteins before and after birth supported the view that the full functional maturation of the bile synthesis and secretion is not occurring until after birth (10, 27).
Interestingly, at no period of liver development, could immunostaining be detected beyond the canalicular system. One might have envisioned a scenario according to which the plasma membrane proteins, whatever their domain in the hepatocyte of adult rats, are distributed in fetal hepatocytes in a random fashion, mature, and eventually move toward their designated location together with the organ's ontogenesis. Such an assumption might have been justified by the well-developed dynamic properties of the hepatocyte plasma membrane proteins: delivery of canalicular proteins to the basolateral domain and then back to the apical domain, for instance, are necessary steps in hepatocyte biogenesis (3). However, from its earliest appearance, immunofluorescence for both Bsep and Mrp2 was detectable exclusively in the apical domain. This finding indicates that, whereas structural and functional maturation of fetal hepatocytes is far from being completed, they already reveal precise canalicular polarization of Bsep and Mrp2 proteins.
In addition to the canalicular membrane, we have anticipated finding fluorescence for either Bsep or Mrp2 intracellularly as well. Signs of Bsep protein were previously detected in the liver of adult rats within the so-called subapical compartment (13). The latter is located in a close proximity to the apical domain of hepatocytes and connects the transcytotic and the apical-to-lysosomal pathways (37). It is also known that such pathological conditions like hyperosmotic stress and cholestasis cause partial redistribution of Mrp2 into subapically located intracellular vesicles (24, 36, 45). As expected, we observed immunofluorescence for Bsep or Mrp2 in areas of the cytoplasm of hepatocytes adjacent to the apical domain where subapical compartment is supposed to be situated, although very seldom in adult rats. The staining was strongest and most readily detectable in the liver of newborn rats and especially 1-wk-old pups. These observations are likely reflecting the different amount of proteins at their final, canalicular localization and/or the need for them to be supplied continuously and to ensure the functional maturation of the canaliculi, because it is known that processes of secretion and reabsorption of bile salts in suckling rats are still functionally incomplete (43, 52). They also imply that subapical compartment, an important crossing of incoming and outgoing messages in the hepatocyte, may be involved in the process of delivery of canalicular transporters. Remarkably, a recent study of Paulusma et al. (36) reported that even when Bsep and Mrp2 undergo internalization toward the intracellular compartment in response to bile duct ligation, they still maintain their colocalization and remain to be active.
In conclusion, the study revealed asynchronous expression and colocalization of Bsep and Mrp2 during pre- and postnatal liver development. Although further studies are needed, our results show that expression of Bsep and Mrp2 during development is likely regulated at the transcriptional level as well as imply that these complementary functioning canalicular transporters are of different physiological significance for the mammalian liver.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Dr. Bruno Stieger, Department of Medicine, University of Zurich, Zurich, Switzerland, for kindly providing the anti-Bsep antibody.
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: V. S. Zinchuk, Dept. of Anatomy and Cell Biology, Kochi Medical School, Kohasu, Okoh-cho, Nankoku, Kochi 783-8505, Japan (E-mail: zinchuk{at}kochi-ms.ac.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpgi.00405.2001
Received 15 September 2001; accepted in final form 16 November 2001.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Adachi, Y,
Kobayashi H,
Kurumi Y,
Shouji M,
Kitano M,
and
Yamamoto T.
ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles.
Hepatology
14:
655-659,
1991[ISI][Medline].
2.
Akita, H,
Suzuki H,
Ito K,
Kinoshita S,
Sato N,
Takikawa H,
and
Sugiyama Y.
Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.
Biochim Biophys Acta
1511:
7-16,
2001[ISI][Medline].
3.
Bartles, JR,
Feracci HM,
Stieger B,
and
Hubbard AL.
Biogenesis of the rat hepatocyte plasma membrane in vivo: comparison of the pathways taken by apical and basolateral proteins using subcellular fractionation.
J Cell Biol
105:
1241-1251,
1987[Abstract].
4.
Borst, P,
Evers R,
Kool M,
and
Wijnholds J.
A family of drug transporters: the multidrug resistance-associated proteins.
J Natl Cancer Inst
92:
1295-1302,
2000
5.
Buchler, M,
Konig J,
Brom M,
Kartenbeck J,
Spring H,
Horie T,
and
Keppler D.
cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats.
J Biol Chem
271:
15091-15098,
1996
6.
Cao, J,
Huang L,
Liu Y,
Hoffman T,
Stieger B,
Meier PJ,
and
Vore M.
Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin.
Hepatology
33:
140-147,
2001[ISI][Medline].
7.
Childs, S,
Yeh RL,
Georges E,
and
Ling V.
Identification of a sister gene to p-glycoprotein.
Cancer Res
55:
2029-2034,
1995[Abstract].
8.
Ciofi Luzzatto, A.
Hepatocyte differentiation during early fetal development in the rat.
Cell Tissue Res
215:
133-142,
1981[ISI][Medline].
9.
Cui, Y,
Konig J,
Buchholz JK,
Spring H,
Leier I,
and
Keppler D.
Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.
Mol Pharmacol
55:
929-937,
1999
10.
DeWolf-Peters, C,
DeVos R,
and
Desmet V.
Electron microscopy and histochemistry of canalicular differentiation in fetal and neonatal liver.
Tissue Cell
4:
379-388,
1977.
11.
Feracci, H,
Connolly TP,
Margolis RN,
and
Hubbard AL.
The establishment of hepatocyte cell surface polarity during fetal liver development.
Dev Biol
123:
73-84,
1987[ISI][Medline].
12.
Gatmaitan, ZC,
and
Arias IM.
ATP-dependent transport systems in the canalicular membrane of the hepatocyte.
Physiol Rev
75:
261-275,
1995
13.
Gerloff, T,
Stieger B,
Hagenbuch B,
Madon J,
Landmann K,
Roth J,
Hofmann AF,
and
Meier PJ.
The sister P-glycoprotein represents the canalicular bile salt export pump of mammalian liver.
J Biol Chem
273:
10046-10050,
1998
14.
Greengard, O,
Federman M,
and
Knox WE.
Cytomorphometry of developing rat liver and its application to enzymic differentiation.
J Cell Biol
52:
261-272,
1972
15.
Haussinger, D,
Schmitt M,
Weiergraber O,
and
Kubitz R.
Short-term regulation of canalicular transport.
Semin Liver Dis
20:
307-321,
2000[ISI][Medline].
16.
Herzfeld, A,
Federman M,
and
Greengard O.
Subcellular morphometric and biochemical analyses of developing rat hepatocytes.
J Cell Biol
57:
475-483,
1973
17.
Hooijberg, JH,
Broxterman HJ,
Kool M,
Assaraf YG,
Peters GJ,
Noordhuis P,
Scheper RJ,
Borst P,
Pinedo HM,
and
Jansen G.
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Cancer Res
59:
2532-2535,
1999
18.
Ito, K,
Suzuki H,
Hirohashi T,
Kume K,
Shimizu T,
and
Sugiyama Y.
Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR.
Am J Physiol Gastrointest Liver Physiol
272:
G16-G22,
1997
19.
Jansen, PLM,
Strautnieks SS,
Jacquemin E,
Hadchouel M,
Sokal EM,
Hooiveld GJEJ,
Koning JH,
De Jager-Krikken A,
Kuipers F,
Stellaard F,
Bijleveld CMA,
Gouw A,
Van Goor H,
Thompson RJ,
and
Muller M.
Hepatocellular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Gastroenterology
117:
1370-1379,
1999[ISI][Medline].
20.
Keppler, D,
and
Konig J.
Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver.
FASEB J
11:
509-516,
1997
21.
Klinger, W.
Biotransformation of drugs and other xenobiotics during postnatal development.
Pharmacol Ther
16:
377-429,
1982[ISI][Medline].
22.
Konig, J,
Nies AT,
Cui Y,
Leier I,
and
Keppler D.
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.
Biochim Biophys Acta
1461:
377-394,
1999[ISI][Medline].
23.
Kool, M,
de Haas M,
Scheffer GL,
Scheper RJ,
van Eijk MJT,
Juijn JA,
Baas F,
and
Borst P.
Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Cancer Res
57:
3537-3547,
1997[Abstract].
24.
Kubitz, R,
D'Urso D,
Keppler D,
and
Haussinger D.
Osmodependent dynamic localization of the multidrug resistance protein 2 in the rat hepatocyte canalicular membrane.
Gastroenterology
113:
1438-1442,
1997[ISI][Medline].
25.
Laemmli, UK.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:
680-685,
1970[ISI][Medline].
26.
Lee, JL,
Trauner M,
Soroka CJ,
Stieger B,
Meier PJ,
and
Boyer JL.
Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.
Gastroenterology
118:
163-172,
2000[ISI][Medline].
27.
Little, JM,
Richey JE,
Van Thiel DH,
and
Lester R.
Taurocholate pool size and distribution in the fetal rat.
J Clin Invest
63:
1042-1049,
1979[ISI][Medline].
28.
Meier, PJ.
Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile.
Am J Physiol Gastrointest Liver Physiol
269:
G801-G812,
1995
29.
Meier, PJ,
and
Stieger B.
Canalicular membrane adenosine triphosphate-dependent transport systems.
Prog Liver Dis
11:
27-44,
1993[Medline].
30.
Moreau, A,
Maurice M,
and
Feldmann G.
Analysis of hepatocyte plasma membrane domains during rat development using monoclonal antibodies.
J Histochem Cytochem
36:
87-94,
1988[Abstract].
31.
Muller, M,
Ishikawa T,
Berger U,
Klunemann C,
Lucka L,
Schreyer A,
Kannicht C,
Reutter W,
Kurz G,
and
Keppler D.
ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt.
J Biol Chem
266:
18920-18926,
1991
32.
Muller, M,
and
Jansen PLM
Molecular aspects of hepatobiliary transport.
Am J Physiol Gastrointest Liver Physiol
272:
G1285-G1303,
1997
33.
Muller, M,
Vos TA,
Koopen NR,
Roelofsen H,
Kuipers F,
and
Jansen PLM
Localization and regulation of a novel canalicular ABC-transporter.
Hepatology
24:
368A,
1996.
34.
Paulusma, CC,
Bosma PJ,
Zaman GJR,
Bakker CTM,
Otter M,
Scheffer GL,
Scheper RJ,
Borst P,
and
Oude Elferink RPJ
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene.
Science
271:
1126-1128,
1996[Abstract].
35.
Paulusma, CC,
Kool M,
Bosma PJ,
Scheffer GL,
ter Borg F,
Scheper RJ,
Tytgat GNJ,
Borst P,
Baas F,
and
Oude Elferink RPJ
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome.
Hepatology
25:
1539-1542,
1997[ISI][Medline].
36.
Paulusma, CC,
Kothe MJC,
Bakker CTM,
Bosma PJ,
van Bokhoven I,
van Marle J,
Bolder U,
Tytgat GNJ,
and
Oude Elferink RPJ
Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver.
Hepatology
31:
684-693,
2000[ISI][Medline].
37.
Rahner, C,
Stieger B,
and
Landmann L.
Apical endocytosis in rat hepatocytes in situ involves clathrin, traverses a subapical compartment, and leads to lysosomes.
Gastroenterology
119:
1692-1707,
2000[ISI][Medline].
38.
Sondheimer, JM,
Bryan H,
Andrews W,
and
Forstner GG.
Cholestatic tendencies in premature infants on and off parenteral nutrition.
Pediatrics
62:
984-989,
1978[ISI][Medline].
39.
Stieger, B,
O'Neill B,
and
Meier PJ.
ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles.
Biochem J
284:
67-74,
1992[ISI][Medline].
40.
Stieger, B,
and
Meier PJ.
Bile acid and xenobiotic transporters in liver.
Curr Opin Cell Biol
10:
462-467,
1998[ISI][Medline].
41.
Stieger, B,
Fattinger K,
Madon J,
Kullak-Ublick GA,
and
Meier PJ.
Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile export pump (Bsep) of rat liver.
Gastroenterology
118:
422-430,
2000[ISI][Medline].
42.
Strautnieks, SS,
Bull LN,
Knisely AS,
Kocoshis SA,
Dahl N,
Arnell H,
Sokal E,
Dahan K,
Childs S,
Ling V,
Tanner MS,
Kagalwalla AF,
Nemeth A,
Pawlowska J,
Baker A,
Mieli-Vergani G,
Freimer NB,
Gardiner RM,
and
Thompson RJ.
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
Nat Genet
20:
233-238,
1998[ISI][Medline].
43.
Suchy, FJ,
Bacuvalas JC,
and
Novak DA.
Determinants of bile formation during development: ontogeny of hepatic bile acid metabolism and transport.
Semin Liver Dis
7:
77-84,
1987[ISI][Medline].
44.
Thomas, TC,
and
McNamee MG.
Purification of membrane proteins.
Methods Enzymol
182:
499-520,
1991[ISI].
45.
Trauner, M,
Arrese M,
Soroka CJ,
Ananthanarayanan M,
Koeppel TA,
Schlosser SF,
Suchy FJ,
Keppler D,
and
Boyer JL.
The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis.
Gastroenterology
113:
255-264,
1997[ISI][Medline].
46.
Trauner, M,
Meier PJ,
and
Boyer JL.
Molecular pathogenesis of cholestasis.
N Engl J Med
339:
1217-1227,
1998
47.
Tsuji, H,
Konig J,
Rost D,
Stockel B,
Leuschner U,
and
Keppler D.
Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome.
Gastroenterology
117:
653-660,
1999[ISI][Medline].
48.
Vore, M.
Canalicular transport-discovery of ATP-dependent mechanisms.
Toxicol Appl Pharmacol
118:
2-7,
1993[ISI][Medline].
49.
Vos, TA,
Hooiveld GJEJ,
Koning H,
Childs S,
Meijer DKF,
Moshage H,
Jansen PLM,
and
Muller M.
Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver.
Hepatology
28:
1637-1644,
1998[ISI][Medline].
50.
Wolters, H,
Kuipers F,
Slooff MJH,
and
Vonk RJ.
Adenosine triphosphate-dependent taurocholate transport in human liver plasma membrane.
J Clin Invest
90:
2321-2326,
1992[ISI][Medline].
51.
Wouterlood, FG,
Van Denderen JCM,
Blijleven N,
Van Minnen J,
and
Hartig W.
Two-laser dual-immunofluorescence confocal laser scanning microscopy using Cy2- and Cy5-conjugated secondary antibodies: unequivocal detection of co-localization of neuronal markers.
Brain Res Brain Res Protocols
2:
149-159,
1998[ISI][Medline].
52.
Yousef, IM,
and
Tuchweber B.
Bile acid composition in neonatal life in rats.
Biol Neonate
42:
105-112,
1982[ISI][Medline].